163 related articles for article (PubMed ID: 38376547)
1. Therapeutic Effects of AF219 on Interstitial Cystitis/Bladder Pain Syndrome Induced by Cyclophosphamide or Water Avoidance Stress in Rats.
Avci IE; Teke K; Gocmez SS; Kasap M; Akpinar G; Yaprak Bayrak B; Celebi G; Sarihan M; Utkan T; Ozkurkcugil C
Int Urogynecol J; 2024 Mar; 35(3):677-688. PubMed ID: 38376547
[TBL] [Abstract][Full Text] [Related]
2. [Effect of electroacupuncture on the expressions of TRPV1, P2X3 receptors in bladder of rats with interstitial cystitis].
Li ZH; Zhao XD; Li W; Han WJ
Zhongguo Zhen Jiu; 2022 Nov; 42(11):1263-8. PubMed ID: 36397224
[TBL] [Abstract][Full Text] [Related]
3. Purinergic P2X7 receptors as therapeutic targets in interstitial cystitis/bladder pain syndrome; key role of ATP signaling in inflammation.
Taidi Z; Mansfield KJ; Bates L; Sana-Ur-Rehman H; Liu L
Bladder (San Franc); 2019; 6(1):e38. PubMed ID: 32775480
[TBL] [Abstract][Full Text] [Related]
4. Temporally complex inflammatory networks in an animal model reveal signatures for interstitial cystitis and bladder pain syndrome phenotype.
Shah AM; Vodovotz Y; Yoshimura N; Chermansky CJ; Fitzgerald J; Tyagi P
Neurourol Urodyn; 2023 Nov; 42(8):1839-1848. PubMed ID: 37587846
[TBL] [Abstract][Full Text] [Related]
5. Trypsin-induced elevated contractile responses in a rat model of interstitial cystitis/bladder pain syndrome: Involvement of PAR2 and intracellular Ca
Denizalti M; Anjum I; Simsek G; Onder SC; Durlu-Kandilci NT
Life Sci; 2022 Mar; 293():120359. PubMed ID: 35092732
[TBL] [Abstract][Full Text] [Related]
6. Activation of GPR18 by Resolvin D2 Relieves Pain and Improves Bladder Function in Cyclophosphamide-Induced Cystitis Through Inhibiting TRPV1.
Lu Q; Yang Y; Zhang H; Chen C; Zhao J; Yang Z; Fan Y; Li L; Feng H; Zhu J; Yi S
Drug Des Devel Ther; 2021; 15():4687-4699. PubMed ID: 34815664
[TBL] [Abstract][Full Text] [Related]
7. Si-Ni-San Ameliorates the Clinical Symptoms of Interstitial Cystitis/Bladder Pain Syndrome in Rats by Decreasing the Expression of Inflammatory Factors.
Yang Y; Shi Z; Yu H; Liu M; Hu T; Han C
Arch Esp Urol; 2023 Jul; 76(5):347-356. PubMed ID: 37545154
[TBL] [Abstract][Full Text] [Related]
8. Suppression of adenosine A
Yang Y; Zhang H; Lu Q; Liu X; Fan Y; Zhu J; Sun B; Zhao J; Dong X; Li L
Biochem Pharmacol; 2021 Jan; 183():114340. PubMed ID: 33189675
[TBL] [Abstract][Full Text] [Related]
9. Serpina3n/serpina3 alleviates cyclophosphamide-induced interstitial cystitis by activating the Wnt/β-catenin signal.
Fang W; Song Q; Lv T; Lv J; Cai Z; Wang Z; Song X; Ji X; Huang J
Int Urol Nephrol; 2023 Dec; 55(12):3065-3075. PubMed ID: 37594700
[TBL] [Abstract][Full Text] [Related]
10. Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC).
Neuhaus J; Schulte-Baukloh H; Stolzenburg JU; Speroni di Fenizio P; Horn LC; Rüffert H; Hartenstein S; Burger M; Schulze M; Schwalenberg T
World J Urol; 2012 Oct; 30(5):693-700. PubMed ID: 21969132
[TBL] [Abstract][Full Text] [Related]
11. Specific inhibition of ICAM-1 effectively reduces bladder inflammation in a rat model of severe non-bacterial cystitis.
Zhang X; He H; Lu G; Xu T; Qin L; Wang X; Jin X; Liu B; Zhao Z; Shen Z; Shao Y
Sci Rep; 2016 Oct; 6():35672. PubMed ID: 27782122
[TBL] [Abstract][Full Text] [Related]
12. Characterization and Validation of a Chronic Model of Cyclophosphamide-Induced Interstitial Cystitis/Bladder Pain Syndrome in Rats.
Augé C; Gamé X; Vergnolle N; Lluel P; Chabot S
Front Pharmacol; 2020; 11():1305. PubMed ID: 32982733
[TBL] [Abstract][Full Text] [Related]
13. Effect of the neuropathic pain receptor P2X3 on bladder function induced by intraperitoneal injection of cyclophosphamide (CYP) in interstitial cystitis rats.
Pang L; Shao J; Wen X; Liu D; Zhang Z; Shuang W
Transl Androl Urol; 2022 Mar; 11(3):304-312. PubMed ID: 35402189
[TBL] [Abstract][Full Text] [Related]
14. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
[TBL] [Abstract][Full Text] [Related]
15. Can the adrenergic system be implicated in the pathophysiology of bladder pain syndrome/interstitial cystitis? A clinical and experimental study.
Charrua A; Pinto R; Taylor A; Canelas A; Ribeiro-da-Silva A; Cruz CD; Birder LA; Cruz F
Neurourol Urodyn; 2015 Jun; 34(5):489-96. PubMed ID: 24375689
[TBL] [Abstract][Full Text] [Related]
16.
Li W; Yang F; Zhan H; Liu B; Cai J; Luo Y; Zhou X
Evid Based Complement Alternat Med; 2020; 2020():9026901. PubMed ID: 33133219
[TBL] [Abstract][Full Text] [Related]
17. A Novel Intravesical Dextrose Injection Improves Lower Urinary Tract Symptoms on Interstitial Cystitis/Bladder Pain Syndrome.
Chen CL; Kao CC; Yang MH; Fan GY; Cherng JH; Tsao CW; Wu ST; Cha TL; Meng E
Front Pharmacol; 2021; 12():755615. PubMed ID: 34975473
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic overlap in overactive bladder and interstitial cystitis/bladder pain syndrome: development of a new algorithm.
Ackerman AL; Lai HH; Parameshwar PS; Eilber KS; Anger JT
BJU Int; 2019 Apr; 123(4):682-693. PubMed ID: 30253040
[TBL] [Abstract][Full Text] [Related]
19. Inflammation and inflammatory control in interstitial cystitis/bladder pain syndrome: Associations with painful symptoms.
Schrepf A; O'Donnell M; Luo Y; Bradley CS; Kreder K; Lutgendorf S;
Pain; 2014 Sep; 155(9):1755-1761. PubMed ID: 24907404
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological management of interstitial cystitis /bladder pain syndrome and the role cyclosporine and other immunomodulating drugs play.
Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
Expert Rev Clin Pharmacol; 2018 May; 11(5):495-505. PubMed ID: 29575959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
